Key Takeaway: The article announces the details of the Annual General Meeting for ImmunoPrecise Antibodies Ltd., scheduled for November 14, 2024. Key dates include the record date for notice and voting, which is set for October 15, 2024. The meeting will be held virtually, and information regarding proxies and access requirements is also outlined. Additional details about the securities involved are provided but do not indicate any significant changes or events affecting the company.
Market Sentiment Analysis
Full Press Release Details
To: All Canadian Securities Regulatory Authorities
AMENDED - SEE HIGHLIGHTED
Subject: IMMUNOPRECISE ANTIBODIES LTD.
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type :
Annual General Meeting
Record Date for Notice of Meeting :
October 15, 2024
Record Date for Voting (if applicable) :
October 15, 2024
Beneficial Ownership Determination Date :
October 15, 2024
Meeting Date :
November 14, 2024
Meeting Location (if available) :
Virtual Meeting
Issuer sending proxy related materials directly to NOBO:
No
Issuer paying for delivery to OBO:
No
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders
No
NAA for Registered Holders
No
Voting Security Details:
Description
CUSIP Number
ISIN
COMMON
45257F200
CA45257F2008
Agent for IMMUNOPRECISE ANTIBODIES LTD.
Frequently Asked Questions
What type of meeting is scheduled for ImmunoPrecise Antibodies Ltd.?
The scheduled meeting is an Annual General Meeting.
When is the record date for voting and notice of the meeting?
The record date for both is October 15, 2024.
When will the Annual General Meeting take place?
The Annual General Meeting will take place on November 14, 2024.
Is the meeting going to be virtual or in-person?
The meeting will be held virtually.
Will ImmunoPrecise Antibodies Ltd. send proxy materials directly?
No, the issuer will not send proxy materials directly to NOBO.